1238TiPA first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma. (23rd October 2018) - Jabulowsky, R A; Loquai, C; Derhovanessian, E; Mitzel-Rink, H; Utikal, J; Hassel, J; Kaufmann, R; Pinter, A; Diken, M; Gold, M; Heesen, L; Schreeb, K H; et al.